Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-25 @ 4:13 AM
NCT ID:
NCT02473120
Eligibility Criteria:
Inclusion Criteria:
* Woman aged superior to 18 years old
* Inform consent signed
* Metastatic breast cancer or loco-regionnaly advanced breast cancer
* Inoperable
* With an indication to treat with aromatase inhibitor
* Treatment with aromatase inhibitors innitiated at the inclusion or at least 6 months before inclusion with a stable disease
* Without precedent treatment or with treatment by chemotherapy/tamoxifen/faslodex or aromatase inhibitors in a adjuvant treatment and with a time frame of 2 years between last treatment with aromatase inhibitors and metastatic evolution
* Treatment by aromatase inhibitors alone or in combination with a targeted therapy (trastuzumab +/- pertuzumab, bevacizumab, everolimus)
Exclusion Criteria:
* No inform consent signed
* Patient under guardianship, curatorship
* Psychosocial disorder
* No affiliated or beneficiary of a social benefit system
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02473120
Study Brief:
Protocol Section:
NCT02473120